IP Library Granted Patent US 10,179,019
Granted Patent B2
US 10,179,019 · App. 14/719,037 · Granted Jan 15, 2019

Integrity testing method and apparatus for delivering vapor to the uterus

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,179,019
App. No.
14/719,037
Granted
Jan 15, 2019
Kind
B2
Abstract

A method and system of providing therapy to a patient's uterus is provided, which can include any number of features. The method can include the steps of inserting a uterine device into the uterus and performing a uterine integrity test to determine that the uterus is intact and not perforated. If it is determined that the uterus is not perforated, a patency test can be performed to determine that the uterine device is not clogged or embedded in tissue. If the uterus is intact and the device is not clogged or embedded in tissue, the uterus can be treated with the uterine device, e.g., uterine ablation. Systems for performing these methods are also disclosed.

Claims (12)

1. A method of performing a patency test for a uterine ablation device, comprising:

inserting the uterine ablation device into a uterus of a patient;

closing an outflow valve to seal an outflow lumen of the uterine ablation device;

delivering gas or fluid from an inflow lumen of the uterine ablation device into the uterus to achieve uterine cavity distension;

opening the outflow valve only partially to remove gas or fluid from the uterus with the outflow lumen of the uterine ablation device while maintaining uterine cavity distension;

determining a flow rate of gas or fluid in the outflow lumen while the outflow lumen is only partially opened;

comparing the flow rate of gas or fluid in the outflow lumen to a threshold value; and

determining that the uterine ablation device is not clogged or embedded in tissue if the flow rate of gas or fluid is above the threshold value.

2. The method of claim 1 , wherein the opening step further comprises:

pulsing the outflow valve a specified duty cycle until a uterine pressure decreases.

3. The method of claim 1 , wherein the opening step further comprises:

pulsing the outflow valve at a first duty cycle, then pulsing the outflow valve at a second duty cycle that is lower than the first duty cycle when flow of gas or fluid through the outflow lumen begins.

Assignments (5)
QUITCLAIM ASSIGNMENT AGREEMENT Recorded Jun 20, 2024
From: AEGEA MEDICAL INC.
To: COOPERSURGICAL, INC.
Reel/Frame 067797/0884 →
RELEASE OF SECURITY INTEREST Recorded Mar 1, 2018
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: AEGEA MEDICAL INC.
Reel/Frame 045482/0001 →
SECURITY AGREEMENT Recorded Dec 28, 2017
From: AEGEA MEDICAL INC.
To: PERCEPTIVE CREDIT HOLDINGS, LP
Reel/Frame 044968/0771 →
SECURITY INTEREST Recorded Oct 13, 2017
From: AEGEA MEDICAL INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND AS A LENDER
Reel/Frame 044261/0696 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2016
From: CHEE, URIEL HIRAM; PELIKS, ROBERT BILGOR; MAGEN, HUGH EDWARD; GURSKIS, DONNELL WILLIAM; BACICH, STEVEN ROBERT
To: AEGEA MEDICAL INC.
Reel/Frame 037577/0183 →